StockNasdaqGSDXCM
Dexcom
$79.41
-4.89 (-5.80%)today
Valuation & earnings
- P/E ratio
- 31.26
- Forward P/E
- 25.33
- EPS (ttm)
- $2.54
- Forward EPS
- $3.13
- Price/book
- 11.68
- PEG ratio
- 1.25
- Dividend yield
- 0%
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 5.1B
- Revenue growth
- 11.2%
- Profit margin
- 19.42%
- Return on equity
- 37.67%
- Total cash
- 1.8B
- Total debt
- 1.4B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 0.65 | 0.68 | +4.5% |
| Mar 31, 2026 | 0.47 | 0.56 | +18.99% |
| Jun 30, 2026 | 0.61 | 0.7 | +15.11% |
| Sep 30, 2026 | 0.67 | 0.73 | +8.31% |
Next earnings date: Oct 29, 2026
Analyst view
Consensus ratingStrong buy29 analysts
Strong buy 4Buy 22Hold 3
12-month price targetsImplied upside: +23.6%
79
98.15
120
LowCurrent priceHigh
Related products
How visible is Dexcom in AI search?
We ask AI search engines about Dexcom and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Dexcom yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.